ParenteralDosed ingredient Cosmetic cross-reference

Sodium Nitrite

CAS 7632-00-0

Sodium Nitrite (CAS 7632-00-0) is a Phase 4 pharmaceutical compound with 3 bioactivity targets and 4 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
6
SOURCE DrugCentral / FAERS
Adverse signals
4
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Sodium Nitrite
CAS Number
7632-00-0
UNII
M0KG633D4F
InChIKey
LPXPTNMVRIOKMN-UHFFFAOYSA-M
ChEMBL ID
CHEMBL93268
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
black box warningdosed ingredientparenteral
SOURCE ChEMBL 36 B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL93268 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE ChEMBL 36 activities + assays 6 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- MIC 1334.857142857143 ug.mL-1 7 -
- Potency 33126.15 nM 6 -
- IC50 94000 nM 1 -
Carbonic anhydrase 2
Enzyme
Ki 1.2 - Homo sapiens
Carbonic anhydrase 1
Enzyme
Ki 2.08 - Homo sapiens
Carbonic anhydrase 13
Enzyme
Ki 1.9 - Mus musculus
SOURCE RxNorm drug names 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
Sodium Nitrite 9894 SU MTHSPL
SODIUM NITRITE 9894 SU MTHSPL
sodium nitrite 9894 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Sodium Nitrite used for in pharmaceutical contexts?

Sodium Nitrite (CAS 7632-00-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Sodium Nitrite?

Sodium Nitrite has 4 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Completed suicide, Exposure to toxic agent, Toxicity to various agents. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Sodium Nitrite also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Nitrite with EU status "restricted".

What clinical phase is Sodium Nitrite in?

Sodium Nitrite is rendered with ChEMBL max phase 4 (approved).

What bioactivity targets are documented for Sodium Nitrite?

Sodium Nitrite has 6 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 2, Carbonic anhydrase 1, Carbonic anhydrase 13.